BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20558936)

  • 21. Successful Treatment of Aspergillus Empyema Using Open Window Thoracostomy Salvage Treatment and the Local Administration of an Antifungal Agent.
    Ashizawa N; Nakamura S; Ide S; Tashiro M; Takazono T; Imamura Y; Miyazaki T; Izumikawa K; Yamamoto Y; Yanagihara K; Miyazaki Y; Kohno S
    Intern Med; 2016; 55(15):2093-9. PubMed ID: 27477422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic antifungal activity of KB425796-C in combination with micafungin against Aspergillus fumigatus and its efficacy in murine infection models.
    Kai H; Yamashita M; Nakamura I; Yoshikawa K; Nitta K; Watanabe M; Inamura N; Fujie A
    J Antibiot (Tokyo); 2013 Aug; 66(8):479-84. PubMed ID: 23756682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
    Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
    Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study.
    Kohno S; Izumikawa K; Kakeya H; Miyazaki Y; Ogawa K; Amitani R; Niki Y; Kurashima A
    Med Mycol; 2011 Oct; 49(7):688-93. PubMed ID: 21355713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis.
    Seyedmousavi S; Brüggemann RJ; Melchers WJ; Rijs AJ; Verweij PE; Mouton JW
    J Antimicrob Chemother; 2013 Feb; 68(2):385-93. PubMed ID: 23129729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii.
    Lackner M; Fernández-Silva F; Guarro J; Lass-Flörl C
    J Antimicrob Chemother; 2014 Nov; 69(11):3027-32. PubMed ID: 24986494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of micafungin in the tissue fluids of patients with invasive fungal infections.
    Yamada N; Kumada K; Kishino S; Mochizuki N; Ohno K; Ogura S
    J Infect Chemother; 2011 Oct; 17(5):731-4. PubMed ID: 21537970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
    Singh N; Limaye AP; Forrest G; Safdar N; Muñoz P; Pursell K; Houston S; Rosso F; Montoya JG; Patton P; Del Busto R; Aguado JM; Fisher RA; Klintmalm GB; Miller R; Wagener MM; Lewis RE; Kontoyiannis DP; Husain S
    Transplantation; 2006 Feb; 81(3):320-6. PubMed ID: 16477215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis.
    Petraitis V; Petraitiene R; Hope WW; Meletiadis J; Mickiene D; Hughes JE; Cotton MP; Stergiopoulou T; Kasai M; Francesconi A; Schaufele RL; Sein T; Avila NA; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2382-91. PubMed ID: 19307368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient.
    Fianchi L; Montini L; Caira M; Voso MT; Maviglia R; Posteraro B; Pagano L
    Infection; 2008 Feb; 36(1):65-7. PubMed ID: 17926005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K; Tredup A; Salvenmoser S; Müller FM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical efficacies of antifungal injections].
    Fujii Y; Inase N; Yoshizawa Y
    Nihon Rinsho; 2008 Dec; 66(12):2378-83. PubMed ID: 19069109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive sino-orbital mycosis in an aplastic anemia patient caused by Neosartorya laciniosa.
    Malejczyk K; Sigler L; Gibas CF; Smith SW
    J Clin Microbiol; 2013 Apr; 51(4):1316-9. PubMed ID: 23345294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
    Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L
    Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults.
    Keirns J; Sawamoto T; Holum M; Buell D; Wisemandle W; Alak A
    Antimicrob Agents Chemother; 2007 Feb; 51(2):787-90. PubMed ID: 17116670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
    Forestier E; Remy V; Lesens O; Martinot M; Hansman Y; Eisenmann B; Christmann D
    Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):347-9. PubMed ID: 15889298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
    Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
    Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of Aspergillus liver abscesses in a patient with acute monoblastic leukemia using combination antifungal therapy including micafungin as a key drug.
    Yamada R; Horikawa K; Ishihara S; Hoshino K; Kawaguchi T; Iyama K; Mitsuya H; Asou N
    Int J Hematol; 2010 May; 91(4):711-5. PubMed ID: 20352380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electron microscopic findings for micafungin-treated experimental pulmonary aspergillosis in mice.
    Nakai T; Hatano K; Ikeda F; Shibuya K
    Med Mycol; 2005 Aug; 43(5):439-45. PubMed ID: 16178373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary aspergillosis caused by a pan-azole-resistant Aspergillus fumigatus in a 10-year-old boy.
    Thors VS; Bierings MB; Melchers WJ; Verweij PE; Wolfs TF
    Pediatr Infect Dis J; 2011 Mar; 30(3):268-70. PubMed ID: 21127455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.